Dose Escalation Versus Standard in Laryngopharyngeal Cancers (INTELHOPE)
Intensifying Radiation Treatment in Advanced/ Poor Prognosis Laryngeal, Hypopharyngeal (LH) and Oropharyngeal Cancers (OPC) Using PET -CT Based Dose Escalation Strategies ( INTELHOPE)
Sponsor: Tata Medical Center
This NA trial investigates Malignant Neoplasm of Hypopharynx Stage III and Malignant Neoplasm of Hypopharynx Stage IVa and is currently completed. Tata Medical Center leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2024 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed · Phase: PHASE1_PHASE2 → NA
-
Jan 2022 — Jan 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2021 — Jan 2022 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 3 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Feb 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Tata Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .